Neurogene (NGNE) Reports In-Line Q3 EPS

Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).

For earnings history and earnings-related data on Neurogene (NGNE) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight
• Crusoe in talks to raise $3B in funding - Bloomberg